SCHEMBL7524877

SCHEMBL7524877

C=CC=CNC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8650911 1.00
SCHEMBL7529498 0.76
SCHEMBL16639034 0.76
SCHEMBL13725985 0.76
SCHEMBL14037955 0.76
SCHEMBL177587 0.76
SCHEMBL28647859 0.74
SCHEMBL23426205 0.72
SCHEMBL14322200 0.72
SCHEMBL14322201 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812311-B1 HIGHLY POLYMERIZABLE N-VINYLCARBOXYLIC ACID AMIDE AND PRODUCTION PROCESS THEREOF SHOWA DENKO KK (JP) 2002-03-20 EP claimed
CN-106574103-B Composition including the polymer based on polylactide 道达尔研究技术弗吕公司 2019-09-17 CN disclosed
CN-106459569-B It include the polymer composition of the block copolymer based on polylactide-polybutadiene 道达尔研究技术弗吕公司 2018-10-19 CN disclosed
CN-106574103-A Composition comprising poly-lactide-based polymer 道达尔研究技术弗吕公司 2017-04-19 CN disclosed
CN-106459569-A Polymer composition comprising poly-lactide-polybutadiene based block copolymer 道达尔研究技术弗吕公司 2017-02-22 CN disclosed
CN-106459570-A Polylactide based compositions 道达尔研究技术弗吕公司 2017-02-22 CN disclosed
US-5807688-A ANTIBODY DIRECTED ANZYME PRODRUG THERAPY ZENECA LIMITED (GB) 1998-09-15 US disclosed
EP-0745673-A2 Catalytic antibody regulated prodrug therapy ZENECA LIMITED (GB) 1996-12-04 EP disclosed